NCT07649759Active, not recruiting
Mindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of Obesity
Source: ClinicalTrials.gov · Last updated 16 Jun 2026
Brief summary (registry, in English)
The goal of this clinical trial is to learn whether a mindfulness-based nutrition group program is feasible and acceptable for adults with obesity who are taking GLP-1 receptor agonist medication and receiving usual medical care, including dietetic counselling. The main questions this study aims to answer are: Can this group program be successfully carried out with adults receiving GLP-1 treatment? Do participants find the program useful, acceptable, and manageable? Are participants willing to attend the sessions, complete the home exercises, and fill in the study questionnaires? Researchers will compare participants who receive the mindfulness-based nutrition group program plus usual care with participants who receive usual care only. Participants in the group program will take part in a 16-week intervention with nine group sessions. They will practice mindful eating, mindfulness exercises, journaling, and peer exchange. All participants will complete questionnaires and body measurements at the start of the study, after 16 weeks, and 12 months after the start of the study. The study does not test a new drug or device. The study team will not make decisions about participants' GLP-1 medication. All medication decisions remain part of usual medical care.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 21 Nov 2025
- Start date
- 1 Feb 2026
- Primary completion date
- 31 Aug 2026
- Lead sponsor
- Bern University of Applied Sciences
- Diseases
- Obesity
- NCT number
- NCT07649759
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 1 Feb 2026 to the primary completion date, 31 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosed substance use disorders (e.g., alcohol)
- Diagnosed severe psychiatric disorders (e.g., psychosis, acute major depression, binge-eating-disorder)
- Medical contraindications that prevent participation in behavioral interventions (e.g., unstable chronic disease)
- Cognitive impairment or language barriers that prevent meaningful participation
Other
- Pregnant or lactating women
- Current participation in another behavioral or weight-related intervention study
Who the study is looking for
- Adults aged ≥18
- Use of GLP-1-RAs for ≥ 4 months
- Ability to provide informed consent
- Sufficient German language proficiency to participate in group sessions and complete questionnaires
- Willingness and ability to participate in a 16-week program and attend follow-up assessments
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bern University of Applied Sciences (BFH), Department of Health Professions, Division of Nutrition and Dietetics Coordinator of this site? Confirm its status | Bern | Switzerland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.